3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gastrointestinal
1
Conditions
Lung Neoplasms
2
Stomach Neoplasms
1
Paranasal Sinus Neoplasms
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Maxillary Sinus Neoplasms
1
Localized Head and Neck Carcinoma
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Interventions
pembrolizumab
30
Nivolumab
11
atezolizumab
8
Docetaxel
8
Cisplatin
7
Carboplatin
7
Gemcitabine
6
fludarabine
5
Trastuzumab
5
Paclitaxel
5
Ipilimumab
5
Fluorouracil
5
Cyclophosphamide
5
spartalizumab
4
cemiplimab
4
avelumab
4
Polymerase Chain Reaction
4
Cetuximab
4
Capecitabine
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
aldesleukin
3
Taxes
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Interleukin-2
3
Gene Expression Profiling
3
Drug Therapy
3
Biopsy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Referral and Consultation
×
Head & Neck
×
Clear all
NCT03102229
2026-04-13
RAMPART
Montefiore Medical Center
Phase NA
Completed
40 enrolled